Kidney Stone Management Market Size, Forecasts Report 2035

Kidney Stone Management Market Size & Share - By Stone Type, By Category, By End Use, Growth Forecast, 2026 - 2035

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Research Methodology

1.1&nbsp;&nbsp;&nbsp; Research approach

1.2&nbsp;&nbsp;&nbsp; Quality commitments

1.2.1&nbsp;&nbsp;&nbsp; GMI AI policy &amp; data integrity commitment

1.2.1.1&nbsp;&nbsp;&nbsp; Source consistency protocol

1.3&nbsp;&nbsp;&nbsp; Research trail &amp; confidence scoring

1.3.1&nbsp;&nbsp;&nbsp; Research trail components

1.3.2&nbsp;&nbsp;&nbsp; Scoring components

1.4&nbsp;&nbsp;&nbsp; Data collection

1.4.1&nbsp;&nbsp;&nbsp; Partial list of primary sources

1.5&nbsp;&nbsp;&nbsp; Data mining sources

1.5.1&nbsp;&nbsp;&nbsp; Paid sources

1.5.1.1&nbsp;&nbsp;&nbsp; Sources, by region

1.6&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.6.1&nbsp;&nbsp;&nbsp; Base year calculation for any one approach

1.7&nbsp;&nbsp;&nbsp; Forecast model

1.7.1&nbsp;&nbsp;&nbsp; Quantified market impact analysis

1.7.1.1&nbsp;&nbsp;&nbsp; Mathematical impact of growth parameters on forecast

1.8&nbsp;&nbsp;&nbsp; Research transparency addendum

1.8.1&nbsp;&nbsp;&nbsp; Source attribution framework

1.8.2&nbsp;&nbsp;&nbsp; Quality assurance metrics

1.8.3&nbsp;&nbsp;&nbsp; Our commitment to trust

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Stone type trends

2.2.3&nbsp;&nbsp;&nbsp; Category trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing prevalence and recurrence rate of kidney stones

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in minimally invasive treatments

3.2.1.3&nbsp;&nbsp;&nbsp; Favourable reimbursement for lithotripsy procedures

3.2.1.4&nbsp;&nbsp;&nbsp; Rising awareness regarding overall kidney health

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of advanced treatment devices

3.2.2.2&nbsp;&nbsp;&nbsp; Potential long-term adverse effects of lithotripsy

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Expansion in emerging markets

3.2.3.2&nbsp;&nbsp;&nbsp; Growth of telemedicine and remote patient monitoring

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

3.10&nbsp;&nbsp;&nbsp; Value chain analysis

3.11&nbsp;&nbsp;&nbsp; Customer insights

3.12&nbsp;&nbsp;&nbsp; Start-up scenarios

3.13&nbsp;&nbsp;&nbsp; Gap analysis

3.14&nbsp; Impact of AI and generative AI on the market

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2025

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.3.1&nbsp;&nbsp;&nbsp; Global

4.3.2&nbsp;&nbsp;&nbsp; North America

4.3.3&nbsp;&nbsp;&nbsp; Europe

4.3.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers &amp; acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships &amp; collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Stone Type, 2022 - 2035 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Calcium oxalate

5.3&nbsp;&nbsp;&nbsp; Struvite

5.4&nbsp;&nbsp;&nbsp; Uric acid

5.5&nbsp;&nbsp;&nbsp; Calcium phosphate

5.6&nbsp;&nbsp;&nbsp; Cysteine

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Category, 2022 - 2035 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Treatment

6.2.1&nbsp;&nbsp;&nbsp; Extracorporeal shock wave lithotripsy (ESWL)

6.2.2&nbsp;&nbsp;&nbsp; Ureteroscopy

6.2.3&nbsp;&nbsp;&nbsp; Percutaneous nephrolithotomy (PCNL)

6.2.4&nbsp;&nbsp;&nbsp; Other treatments

6.3&nbsp;&nbsp;&nbsp; Diagnostics

6.3.1&nbsp;&nbsp;&nbsp; Computed tomography

6.3.2&nbsp;&nbsp;&nbsp; Ultrasound

6.3.3&nbsp;&nbsp;&nbsp; Abdominal x-ray

6.3.4&nbsp;&nbsp;&nbsp; Intravenous pyelography

6.3.5&nbsp;&nbsp;&nbsp; Abdominal MRI

6.3.6&nbsp;&nbsp;&nbsp; Other diagnostics

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Specialty clinics

7.4&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Allengers

9.2&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

9.3&nbsp;&nbsp;&nbsp; Boston Scientific

9.4&nbsp;&nbsp;&nbsp; Coloplast

9.5&nbsp;&nbsp;&nbsp; COOK MEDICAL

9.6&nbsp;&nbsp;&nbsp; DirexGroup

9.7&nbsp;&nbsp;&nbsp; Dornier MedTech

9.8&nbsp;&nbsp;&nbsp; ELMED Medical Systems

9.9&nbsp;&nbsp;&nbsp; EMS ELECTRO MEDICAL SYSTEMS

9.10&nbsp;&nbsp;&nbsp; KARL STORZ

9.11&nbsp;&nbsp;&nbsp; MEDISPEC

9.12&nbsp;&nbsp;&nbsp; OLYMPUS

9.13&nbsp;&nbsp;&nbsp; PolyDiagnost

9.14&nbsp;&nbsp;&nbsp; Richard Wolf

9.15&nbsp;&nbsp;&nbsp; SIEMENS Healthineers

Kidney Stone Management Market

Inquiry Before Buying